| Authors: |
Jakob V; Vaccine Formulation Laboratory, University of Lausanne, Epalinges, Switzerland., Brunner L; Vaccine Formulation Laboratory, University of Lausanne, Epalinges, Switzerland., Barnier-Quer C; Vaccine Formulation Laboratory, University of Lausanne, Epalinges, Switzerland., Blust M; Infectious Disease Research Institute, Seattle, WA, USA., Collin N; Vaccine Formulation Laboratory, University of Lausanne, Epalinges, Switzerland., Carter L; Infectious Disease Research Institute, Seattle, WA, USA., Carter D; Infectious Disease Research Institute, Seattle, WA, USA, and Department of Global Health, University of Washington, Seattle, WA, USA., Rausch KM; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Fox CB; Infectious Disease Research Institute, Department of Global Health, University of Washington, 1616 Eastlake Ave E Ste 400, Seattle, WA 98102, USA. |
